Azitra Inc (AZTR)

$0.26 0.00 (-0.69%)
Market Cap 4.39M
Revenue (ttm) 10,000.00
Net Income (ttm) -8.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -89,700.00%
Debt to Equity Ratio 0.00
Volume 687,197
Avg Vol 3,422,618
Day's Range N/A - N/A
Shares Out 17.23M
Stochastic %K 27%
Beta -1.78
Analysts Strong Sell
Price Target $2.50

Company Profile

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis that is in Phase 1/2 clinical trial for treating the papulopustular ras...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 646 6446
Address:
21 Business Park Drive, Branford, United States
Gconstance88
Gconstance88 Jun. 27 at 7:10 PM
$AZTR this is holding up for a down market today. Everytime it wants to start moving though it gets shot down. If it can get to .28 or .29 range then this will start rolling.
0 · Reply
pbacher
pbacher Jun. 27 at 6:54 PM
$AZTR
0 · Reply
megamaven
megamaven Jun. 26 at 11:10 AM
$AZTR typical bio price action. Sad to see such market manipulation. When u get a homerun, big pharma scoops it up for pennies.
0 · Reply
pbacher
pbacher Jun. 25 at 4:29 PM
$AZTR
0 · Reply
pbacher
pbacher Jun. 25 at 12:41 PM
$AZTR i think that we will see a pump very very soon
0 · Reply
IMANEEDSMONEY
IMANEEDSMONEY Jun. 25 at 12:11 AM
$AZTR I dreamed this hits 12
0 · Reply
pbacher
pbacher Jun. 24 at 7:50 PM
$AZTR level 2
0 · Reply
PURPLEBOY44
PURPLEBOY44 Jun. 24 at 5:44 PM
$AZTR
0 · Reply
PURPLEBOY44
PURPLEBOY44 Jun. 24 at 5:43 PM
$AZTR maybe News???????? just my opinion
1 · Reply
pbacher
pbacher Jun. 24 at 5:38 PM
$AZTR =))
0 · Reply
Latest News on AZTR
Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Jun 17, 2025, 8:02 AM EDT - 10 days ago

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Jun 10, 2025, 8:33 AM EDT - 17 days ago

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

May 28, 2025, 8:33 AM EDT - 4 weeks ago

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

May 14, 2025, 4:05 PM EDT - 6 weeks ago

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

May 13, 2025, 5:06 PM EDT - 6 weeks ago

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Apr 25, 2025, 8:33 AM EDT - 2 months ago

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Apr 24, 2025, 4:05 PM EDT - 2 months ago

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Azitra to Present at Microbiome Times Partnering Forum

Mar 12, 2025, 8:33 AM EDT - 3 months ago

Azitra to Present at Microbiome Times Partnering Forum

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Feb 24, 2025, 8:30 AM EST - 4 months ago

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Feb 4, 2025, 2:20 PM EST - 5 months ago

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Feb 3, 2025, 9:05 AM EST - 5 months ago

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Azitra, Inc. to Present at The Microcap Conference

Jan 27, 2025, 4:05 PM EST - 5 months ago

Azitra, Inc. to Present at The Microcap Conference

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Jan 15, 2025, 8:30 AM EST - 5 months ago

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Azitra Announces Proposed Public Offering of Common Stock

Jan 14, 2025, 4:05 PM EST - 5 months ago

Azitra Announces Proposed Public Offering of Common Stock

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Nov 12, 2024, 5:05 PM EST - 8 months ago

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Azitra to Present at BIO-Europe 2024

Oct 29, 2024, 9:00 AM EDT - 8 months ago

Azitra to Present at BIO-Europe 2024

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:00 AM EDT - 9 months ago

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Sep 24, 2024, 8:00 AM EDT - 9 months ago

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Sep 18, 2024, 9:00 AM EDT - 10 months ago

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 4:30 PM EDT - 10 months ago

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 28, 2024, 8:30 AM EDT - 10 months ago

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Aug 22, 2024, 9:00 AM EDT - 11 months ago

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 20, 2024, 4:15 PM EDT - 11 months ago

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

Aug 12, 2024, 6:23 PM EDT - 11 months ago

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

Jul 25, 2024, 5:57 PM EDT - 1 year ago

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

Jul 25, 2024, 1:54 PM EDT - 1 year ago

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

HAL

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

Jul 25, 2024, 1:13 PM EDT - 1 year ago

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

HAL

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Jul 23, 2024, 9:20 PM EDT - 1 year ago

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Jul 23, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Azitra, Inc. Announces Reverse Stock Split

Jun 27, 2024, 4:05 PM EDT - 1 year ago

Azitra, Inc. Announces Reverse Stock Split

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

May 31, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

May 17, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

May 10, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting

Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates

May 9, 2024, 5:00 PM EDT - 1 year ago

Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates

Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting

Apr 22, 2024, 4:30 PM EDT - 1 year ago

Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting

Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024

Apr 18, 2024, 4:15 PM EDT - 1 year ago

Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024

Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

Mar 15, 2024, 4:15 PM EDT - 1 year ago

Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates

Azitra, Inc. Announces Closing of Public Offering

Feb 16, 2024, 4:05 PM EST - 1 year ago

Azitra, Inc. Announces Closing of Public Offering

Azitra, Inc. Announces Pricing of Public Offering

Feb 13, 2024, 10:09 PM EST - 1 year ago

Azitra, Inc. Announces Pricing of Public Offering

Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US

Jan 16, 2024, 9:00 AM EST - 1 year ago

Azitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the US

Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference

Jan 3, 2024, 9:00 AM EST - 1 year ago

Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare Conference

Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates

Nov 14, 2023, 4:30 PM EST - 1 year ago

Azitra, Inc. Announces Third Quarter 2023 Financial Results and Business Updates

Azitra to Present at the ThinkEquity Conference

Oct 16, 2023, 8:00 AM EDT - 1 year ago

Azitra to Present at the ThinkEquity Conference

Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 29, 2023, 8:00 AM EDT - 1 year ago

Azitra to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates

Aug 14, 2023, 4:05 PM EDT - 2 years ago

Azitra, Inc. Announces Second Quarter 2023 Financial Results and Business Updates

Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors

Jul 19, 2023, 4:05 PM EDT - 2 years ago

Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Its Board of Directors

Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer

Jul 11, 2023, 4:05 PM EDT - 2 years ago

Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer

Azitra, Inc. Announces Closing of Initial Public Offering

Jun 21, 2023, 6:46 PM EDT - 2 years ago

Azitra, Inc. Announces Closing of Initial Public Offering

Azitra, Inc. Announces Pricing of Initial Public Offering

Jun 15, 2023, 7:04 PM EDT - 2 years ago

Azitra, Inc. Announces Pricing of Initial Public Offering

U.S. IPO Weekly Recap: No IPOs, But The Pipeline Gets A Pickup With 3 New Filers

Jun 10, 2023, 5:30 AM EDT - 2 years ago

U.S. IPO Weekly Recap: No IPOs, But The Pipeline Gets A Pickup With 3 New Filers

BOF CAVA PXDT SRFM

Gconstance88
Gconstance88 Jun. 27 at 7:10 PM
$AZTR this is holding up for a down market today. Everytime it wants to start moving though it gets shot down. If it can get to .28 or .29 range then this will start rolling.
0 · Reply
pbacher
pbacher Jun. 27 at 6:54 PM
$AZTR
0 · Reply
megamaven
megamaven Jun. 26 at 11:10 AM
$AZTR typical bio price action. Sad to see such market manipulation. When u get a homerun, big pharma scoops it up for pennies.
0 · Reply
pbacher
pbacher Jun. 25 at 4:29 PM
$AZTR
0 · Reply
pbacher
pbacher Jun. 25 at 12:41 PM
$AZTR i think that we will see a pump very very soon
0 · Reply
IMANEEDSMONEY
IMANEEDSMONEY Jun. 25 at 12:11 AM
$AZTR I dreamed this hits 12
0 · Reply
pbacher
pbacher Jun. 24 at 7:50 PM
$AZTR level 2
0 · Reply
PURPLEBOY44
PURPLEBOY44 Jun. 24 at 5:44 PM
$AZTR
0 · Reply
PURPLEBOY44
PURPLEBOY44 Jun. 24 at 5:43 PM
$AZTR maybe News???????? just my opinion
1 · Reply
pbacher
pbacher Jun. 24 at 5:38 PM
$AZTR =))
0 · Reply
pbacher
pbacher Jun. 24 at 12:09 PM
$AZTR
1 · Reply
dln101
dln101 Jun. 24 at 8:35 AM
$ADIL 💪🔥🚀 pennies back in play 🤔 $AZTR $VTAK
0 · Reply
pbacher
pbacher Jun. 23 at 9:14 PM
$AZTR Azitra’s 2025 annual meeting approved director elections and accounting firm ratification. Voting on increasing authorized shares was adjourned to July 3, 2025.
0 · Reply
pbacher
pbacher Jun. 23 at 6:21 PM
$AZTR anyone have news from the meeting today?
0 · Reply
pbacher
pbacher Jun. 23 at 5:46 PM
$AZTR
0 · Reply
pbacher
pbacher Jun. 23 at 5:00 PM
$AZTR and another ATL
0 · Reply
pbacher
pbacher Jun. 23 at 2:18 PM
$AZTR new ATL...
0 · Reply
pbacher
pbacher Jun. 23 at 1:55 PM
$AZTR zero
0 · Reply
pbacher
pbacher Jun. 23 at 12:05 PM
$AZTR
0 · Reply
davooo
davooo Jun. 23 at 10:48 AM
$AZTR Here we go 🙄
0 · Reply
lachanceKdance
lachanceKdance Jun. 21 at 12:00 AM
$AZTR and dilution!
1 · Reply
EdgeLeak
EdgeLeak Jun. 20 at 11:57 PM
$AZTR Contraction... leads to EXPANSION few understand
0 · Reply